4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System

Abstract

4H (hypomyelination, hypodontia and hypogonadotropic hypogonadism) leukodystrophy (4H) is an autosomal recessive hypomyelinating white matter (WM) disorder with neurologic, dental, and endocrine abnormalities. The aim of this study was to develop and validate a magnetic resonance imaging (MRI) scoring system for 4H. A scoring system (0–54) was developed to quantify hypomyelination and atrophy of different brain regions. Pons diameter and bicaudate ratio were included as measures of cerebral and brainstem atrophy, and reference values were determined using controls. Five independent raters completed the scoring system in 40 brain MRI scans collected from 36 patients with genetically proven 4H. Interrater reliability (IRR) and correlations between MRI scores, age, gross motor function, gender, and mutated gene were assessed. IRR for total MRI severity was found to be excellent (intraclass correlation coefficient: 0.87; 95% confidence interval: 0.80–0.92) but varied between different items with some (e.g., myelination of the cerebellar WM) showing poor IRR. Atrophy increased with age in contrast to hypomyelination scores. MRI scores (global, hypomyelination, and atrophy scores) significantly correlated with clinical handicap (p < 0.01 for all three items) and differed between the different genotypes. Our 4H MRI scoring system reliably quantifies hypomyelination and atrophy in patients with 4H, and MRI scores reflect clinical disease severity.

Keywords

4H - leukodystrophy - MRI - hypomyelination

^* The authors contributed equally to this work.

^‡ The authors contributed equally to this work.

• References

• 1 Pouwels PJ, Vanderver A, Bernard G , et al. Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol 2014; 76 (1) 5-19
• 2 Steenweg ME, Wolf NI, van Wieringen WN, Barkhof F, van der Knaap MS, Pouwels PJ. Quantitative MRI in hypomyelinating disorders: correlation with motor handicap. Neurology 2016; 87 (8) 752-758
• 3 Loes DJ, Hite S, Moser H , et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994; 15 (9) 1761-1766
• 4 Eichler F, Grodd W, Grant E , et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol 2009; 30 (10) 1893-1897
• 5 Sarret C, Lemaire JJ, Tonduti D , et al. Time-course of myelination and atrophy on cerebral imaging in 35 patients with PLP1-related disorders. Dev Med Child Neurol 2016; 58 (7) 706-713
• 6 Cayami FK, La Piana R, van Spaendonk RM , et al. POLR3A and POLR3B mutations in unclassified hypomyelination. Neuropediatrics 2015; 46 (3) 221-228
• 7 Wolf NI, Harting I, Boltshauser E , et al. Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology 2005; 64 (8) 1461-1464
• 8 Timmons M, Tsokos M, Asab MA , et al. Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. Neurology 2006; 67 (11) 2066-2069
• 9 Wolf NI, Harting I, Innes AM , et al. Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. Neuropediatrics 2007; 38 (2) 64-70
• 10 Bernard G, Chouery E, Putorti ML , et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 2011; 89 (3) 415-423
• 11 Saitsu H, Osaka H, Sasaki M , et al. Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet 2011; 89 (5) 644-651
• 12 Daoud H, Tétreault M, Gibson W , et al. Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. J Med Genet 2013; 50 (3) 194-197
• 13 Thiffault I, Wolf NI, Forget D , et al. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat Commun 2015; 6: 7623
• 14 Tétreault M, Choquet K, Orcesi S , et al. Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am J Hum Genet 2011; 89 (5) 652-655
• 15 Wolf NI, Vanderver A, van Spaendonk RM , et al; 4H Research Group. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology 2014; 83 (21) 1898-1905
• 16 Steenweg ME, Vanderver A, Blaser S , et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 2010; 133 (10) 2971-2982
• 17 Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39 (4) 214-223
• 18 Mayson TA, Ward V, Davies KR , et al. Reliability of retrospective assignment of gross motor function classification system scores. Dev Neurorehabil 2013; 16 (3) 207-209
• 19 Cicchetti DV. Multiple comparison methods: establishing guidelines for their valid application in neuropsychological research. J Clin Exp Neuropsychol 1994; 16 (1) 155-161
• 20 Butzkueven H, Kolbe SC, Jolley DJ , et al. Validation of linear cerebral atrophy markers in multiple sclerosis. J Clin Neurosci 2008; 15 (2) 130-137
• 21 Raininko R, Autti T, Vanhanen SL, Ylikoski A, Erkinjuntti T, Santavuori P. The normal brain stem from infancy to old age. A morphometric MRI study. Neuroradiology 1994; 36 (5) 364-368
• 22 Caon C, Zvartau-Hind M, Ching W, Lisak RP, Tselis AC, Khan OA. Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis. Neurology 2003; 60 (2) 323-325
• 23 Brickman AM, Honig LS, Scarmeas N , et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol 2008; 65 (9) 1202-1208
• 24 Laukka JJ, Stanley JA, Garbern JY , et al. Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease. J Neurol Sci 2013; 335 (1-2): 75-81
• 25 Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5 (2) 158-170
• 26 Roosendaal SD, Bendfeldt K, Vrenken H , et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 2011; 17 (9) 1098-1106
• 27 La Piana R, Cayami FK, Tran LT , et al. Diffuse hypomyelination is not obligate for POLR3-related disorders. Neurology 2016; 86 (17) 1622-1626